Voyager Therapeutics Inc (NASDAQ: VYGR) kicked off on Tuesday, down -4.80% from the previous trading day, before settling in for the closing price of $4.17. Over the past 52 weeks, VYGR has traded in a range of $3.80-$10.66.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 126.57% over the past five years. While this was happening, its average annual earnings per share was recorded -28.93%. With a float of $44.40 million, this company’s outstanding shares have now reached $54.54 million.
Let’s look at the performance matrix of the company that is accounted for 162 employees. In terms of profitability, gross margin is 77.42%, operating margin of 5.54%, and the pretax margin is 16.35%.
Voyager Therapeutics Inc (VYGR) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Voyager Therapeutics Inc is 18.72%, while institutional ownership is 63.48%. The most recent insider transaction that took place on Feb 20 ’25, was worth 14,079. In this transaction Chief Scientific Officer of this company sold 3,305 shares at a rate of $4.26, taking the stock ownership to the 77,718 shares. Before that another transaction happened on Feb 20 ’25, when Company’s President and CEO sold 11,702 for $4.24, making the entire transaction worth $49,616. This insider now owns 296,816 shares in total.
Voyager Therapeutics Inc (VYGR) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -28.93% per share during the next fiscal year.
Voyager Therapeutics Inc (NASDAQ: VYGR) Trading Performance Indicators
Take a look at Voyager Therapeutics Inc’s (VYGR) current performance indicators. Last quarter, stock had a quick ratio of 8.45. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.72, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -1.58 in one year’s time.
Technical Analysis of Voyager Therapeutics Inc (VYGR)
Voyager Therapeutics Inc (NASDAQ: VYGR) saw its 5-day average volume 0.35 million, a negative change from its year-to-date volume of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 64.10%. Additionally, its Average True Range was 0.24.
During the past 100 days, Voyager Therapeutics Inc’s (VYGR) raw stochastic average was set at 3.80%, which indicates a significant decrease from 28.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.44% in the past 14 days, which was lower than the 78.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.99, while its 200-day Moving Average is $6.60. Nevertheless, the first resistance level for the watch stands at $4.14 in the near term. At $4.31, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.43. If the price goes on to break the first support level at $3.85, it is likely to go to the next support level at $3.72. The third support level lies at $3.55 if the price breaches the second support level.
Voyager Therapeutics Inc (NASDAQ: VYGR) Key Stats
The company with the Market Capitalisation of 216.86 million has total of 54,626K Shares Outstanding. Its annual sales at the moment are 250,010 K in contrast with the sum of 132,330 K annual income. Company’s last quarter sales were recorded 24,630 K and last quarter income was -9,040 K.
